Healthcare
Comprehensive Healthcare Systems, Inc.(CHS)
Live Price
Offline$0.48
-1.03% today
1Y Change
-26.98%
Window
Jun 25, 2025 β Jun 16, 2026
- Market Cap
- $940.00M
- Revenue Growth
- +18.3%
- EPS Growth
- +133.3%
- Dividend Yield
- 0.0%
Coverage: 244 bars Β· Jun 25, 2025 β Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Comprehensive Healthcare Systems, Inc. (CHS) is a Healthcare stock with a market cap of $940.00M and listed on TSXV. The stock last traded around $0.48 and down 27.0% across the available one-year price window (Jun 25, 2025 β Jun 16, 2026). Baseline metrics include revenue growth of +18.3%, EPS growth of +133.3%, a dividend yield of 0.0%. What stands out right now is revenue +18.3%, EPS +133.3%, free cash flow +142.3% with operating margin 6.6% and ROIC 10.7%. Valuation is more restrained than many high-expectation growth names at P/E 8.4 and price/sales 0.4. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines CHS price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+18.3% vs +7.6% peer median
Operating Margin
Below sector median
+6.6% vs +19.4% peer median
P/E
Below sector median
8.4 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report landed above expectations
2024 was reported on Feb 27, 2024 with an EPS surprise of +500.0%.
The operating story is still moving forward
Revenue is running at +18.3% and EPS at +133.3%, with operating margin around 6.6%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +7.9% over the next 5 trading days and finished higher after 3 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS Ξ | 1D | 5D | 20D |
|---|---|---|---|---|
2024 Feb 27, 2024 | +500.0% | +0.0% | +7.9% | +9.5% |
2023 Nov 30, 2023 | +10.0% | +0.0% | +7.9% | +9.5% |
2023 Aug 29, 2023 | +3.7% | +0.0% | +7.9% | +9.5% |
Benchmark Edge
CHS vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
CHS
β
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
CHS Max Drawdown
-52.11%
Trailing 1Y
SPY Max Drawdown
β
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for CHS and SPY.
Company Overview
Comprehensive Healthcare Systems, Inc.
TSXV
Comprehensive Healthcare Systems, Inc. is a vertically integrated software-as-a-service (SaaS) provider specializing in digitizing healthcare administration. Its primary function is to deliver robust, cloud-based solutions for healthcare benefits administration, medical management, and third-party administration. The company's core offering is the Novus 360 platform, which streamlines processes such as claims processing, benefits administration, price transparency, medical and pharmacy benefit management, and financial recovery, allowing clientsβincluding unions, government entities, providers, self-insured employers, and payorsβto simplify workflows and enhance operational efficiency. Comprehensive Healthcare Systems, Inc. stands out for its customizable and HIPAA-compliant technology, backed by a leadership team with decades of healthcare and benefits experience. Serving the broader healthcare industry, it addresses critical administrative challenges, supporting cost control and regulatory compliance. Its solutions are integral in helping organizations provide clear, accessible, and compliant healthcare management at scale, highlighting its role as a key enabler of digital transformation in health information services.
- Leadership
- Mr. Chris Cosgrove
- Street Address
- 515 Plainfield Ave, Suite 103
- Mailing
- Edison, NJ, 08817
- Region
- Edison, NJ, United States
- Last Updated
- May 7, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 8.4
- EV/EBITDA
- 7.1
- Price/Sales
- 0.4
- Price/Book
- 2.7
Growth
- Revenue
- +18.3%
- EPS
- +133.3%
- Free Cash Flow
- +142.3%
Profitability
- Gross Margin
- 39.1%
- Operating Margin
- 6.6%
- Net Margin
- 5.1%
- ROE
- 39.1%
- ROIC
- 10.7%
Balance Sheet
- Debt/Equity
- 1.64
- Current Ratio
- 1.14
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.